Message 2: The Effect of Message Content and Clinical Outcome on Patient's Perception of Physician Compassion

March 15, 2019 updated by: M.D. Anderson Cancer Center
The goal of this research study is to learn how patients view their doctor's compassion about supportive care and treatment options for advanced cancer patients.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

If you agree to take part in this study, during an already scheduled office visit, you will complete the following:

  • Basic information about you will be collected from your medical record (such as your date of birth, date of diagnosis, sex, and religion).
  • You will complete 4 questionnaires about any symptoms you may be having, how hopeful you are in general, how you are dealing with the disease, your trust in the medical profession, and your strength of religious faith. It should take about 10 minutes total to complete all questionnaires.

You will then be randomly assigned (as in the flip of a coin) to 1 of 2 groups. Each group will watch a short video that shows actors playing a doctor and patient having a conversation about different cancer treatment options. Each video is about 4 minutes long and will discuss the same material, but the message shown in the videos will be different for each group.

After you watch the video, you will complete 3 questionnaires that will ask about your impression of the doctor in the video, how hopeful you think the doctor was, if you think the doctor was professional, and how you would rate the doctor overall. It should take about 8 minutes total to complete all questionnaires.

You will then read a small story about the patient in the video. Afterwards, you will complete the same 3 questionnaires that you filled out after you watched the video. You will also complete an additional questionnaire about your impression of the doctor's compassion and trustworthiness. This should take less than 10 minutes to complete.

Length of Study:

It should take about 25 minutes total to watch the video and to complete all questionnaires. Your active participation on this study will be over after you have completed the last questionnaire.

Other Information:

You are taking part in this study alone. Your family members will not be in the room with you. If you request, your family may be able remain in the room, but the investigators ask that they remain silent.

This is an investigational study.

Up to 128 participants will be enrolled in this study. All will take part at MD Anderson.

Study Type

Interventional

Enrollment (Actual)

148

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Texas
      • Houston, Texas, United States, 77030
        • University of Texas MD Anderson Cancer Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Diagnosis of advanced cancer, defined as locally advanced, recurrent or metastatic disease
  2. Follow up patients seen in the outpatient Supportive Care Center.
  3. Age >/= 18 years-old
  4. English speaking

Exclusion Criteria:

  1. Altered cognitive status as determined by the interviewer based on the ability to understand the nature of the study and consent process.
  2. Patients suffering from a severe psychiatric disorder or condition that would significantly interfere with study participation, as determined by the Principal Investigator or by the attending palliative care physician.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Video 1 + Questionnaires
Participants complete 4 questionnaires at baseline. Participants then watch a short video. At end of video, 3 questionnaires completed. Participants then read a small story about the patient in the video. Afterwards, another set of questionnaires completed.
Behavioral: Questionnaires
Participants complete questionnaires at baseline, after watching a video, and after reading a story about the patient in the video.
Other Names:
  • Surveys
Behavioral: Video
Participants watch a video lasting about 4 minutes.
Experimental: Video 2 + Questionnaires
Participants complete 4 questionnaires at baseline. Participants then watch a short video. At end of video, 3 questionnaires completed. Participants then read a small story about the patient in the video. Afterwards, another set of questionnaires completed.
Behavioral: Questionnaires
Participants complete questionnaires at baseline, after watching a video, and after reading a story about the patient in the video.
Other Names:
  • Surveys
Behavioral: Video
Participants watch a video lasting about 4 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rating of Physician's Compassion
Time Frame: 1 day
Participant's rating of physician's compassion scored by using a 5-item tool consisting of five 0-10 numerical rating scales assessing five dimensions: warm-cold, pleasant-unpleasant, compassionate-distant, sensitive insensitive, caring-uncaring. Sum of the five scales gives a final score representing physician's compassion with a 0 to 50 scale.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

M.D. Anderson Cancer Center

Investigators

  • Principal Investigator: Kimberson C. Tanco, MD, M.D. Anderson Cancer Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2015

Primary Completion (Actual)

December 6, 2018

Study Completion (Actual)

December 6, 2018

Study Registration Dates

First Submitted

July 13, 2015

First Submitted That Met QC Criteria

July 14, 2015

First Posted (Estimate)

July 15, 2015

Study Record Updates

Last Update Posted (Actual)

March 19, 2019

Last Update Submitted That Met QC Criteria

March 15, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2015-0279
  • NCI-2015-01553 (Registry Identifier: NCI CTRP)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Advanced Cancers

Clinical Trials on Questionnaires

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe